Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease

NCT06992804 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

OTHER: NirsCure with Lecanemab
OTHER: sham NirsCure with Lecanemab
OTHER: NirsCure with Lecanemab

Sponsor

Xuanwu Hospital, Beijing